- Home
- TRUP vs RXRX Comparison
TRUP vs RXRX Comparison
Compare TRUP & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRUP
- RXRX
- Stock Information
- Founded
- TRUP 2000
- RXRX 2013
- Country
- TRUP United States
- RXRX United States
- Employees
- TRUP N/A
- RXRX N/A
- Industry
- TRUP Medical Specialities
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- TRUP Health Care
- RXRX Health Care
- Exchange
- TRUP Nasdaq
- RXRX Nasdaq
- Market Cap
- TRUP 2.0B
- RXRX 2.4B
- IPO Year
- TRUP 2014
- RXRX 2021
- Fundamental
- Price
- TRUP $46.32
- RXRX $4.68
- Analyst Decision
- TRUP Buy
- RXRX Buy
- Analyst Count
- TRUP 5
- RXRX 5
- Target Price
- TRUP $55.60
- RXRX $7.00
- AVG Volume (30 Days)
- TRUP 565.1K
- RXRX 17.5M
- Earning Date
- TRUP 08-07-2025
- RXRX 08-05-2025
- Dividend Yield
- TRUP N/A
- RXRX N/A
- EPS Growth
- TRUP N/A
- RXRX N/A
- EPS
- TRUP 0.25
- RXRX N/A
- Revenue
- TRUP $1,360,295,000.00
- RXRX $64,596,000.00
- Revenue This Year
- TRUP $12.62
- RXRX $24.09
- Revenue Next Year
- TRUP $6.70
- RXRX $20.99
- P/E Ratio
- TRUP $184.22
- RXRX N/A
- Revenue Growth
- TRUP 13.11
- RXRX 30.14
- 52 Week Low
- TRUP $31.00
- RXRX $3.79
- 52 Week High
- TRUP $57.90
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- TRUP 36.69
- RXRX 38.30
- Support Level
- TRUP $46.05
- RXRX $4.80
- Resistance Level
- TRUP $46.89
- RXRX $5.01
- Average True Range (ATR)
- TRUP 1.27
- RXRX 0.25
- MACD
- TRUP -0.18
- RXRX -0.06
- Stochastic Oscillator
- TRUP 15.42
- RXRX 8.79
About TRUP Trupanion Inc.
Trupanion Inc is a specialty insurance products provider in the United States. Its core business is the sale of insurance products tailor-made for pets, especially cats and dogs. It operates in two business segments: The subscription business segment generates revenue majorly from subscription fees related to the Company's direct-to-consumer products and Other business segment is comprised of revenue from other product offerings that generally have a business-to-business relationship and a different margin profile than subscription business segment, including revenue from writing policies on behalf of third parties and revenue from other products and software solutions.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.